Adial Pharmaceuticals has filed to register up to 5 million shares of common stock for resale by Alumni Capital LP. The shares include 68,807 commitment shares already issued and up to 4,931,193 additional shares that may be issued under a $5 million purchase agreement.The purchase agreement allows Adial to sell shares to Alumni Capital at 97% of the lowest daily VWAP over a 3-day period, subject to certain volume and price limitations. Proceeds will be used for strategic opportunities, working capital and general corporate purposes.The offering provides Adial with a flexible source of funding, but comes with risks of dilution for existing shareholders. The actual number of shares sold and proceeds received will depend on the company's capital needs and prevailing market conditions.

Adial Pharmaceuticals has filed to register up to 5 million shares of common stock for resale by Alumni Capital LP. The shares include 68,807 commitment shares already issued and up to 4,931,193 additional shares that may be issued under a $5 million purchase agreement.The purchase agreement allows Adial to sell shares to Alumni Capital at 97% of the lowest daily VWAP over a 3-day period, subject to certain volume and price limitations. Proceeds will be used for strategic opportunities, working capital and general corporate purposes.The offering provides Adial with a flexible source of funding, but comes with risks of dilution for existing shareholders. The actual number of shares sold and proceeds received will depend on the company's capital needs and prevailing market conditions.